CAS 212142-18-2 appears in our catalog under these names: Vatalanib succinate, Vatalanib succinate, Vatalanib Succinate, >98.0%(HPLC)(T), Vatalanib (succinate), Vatalanib succinate, 99%. Offered by: GLPBio, TargetMol, Biosynth, TCI, MedChemExpress. Available pack sizes: 10mg, 50mg, 25mg, 100mg, 250mg, 10 mg, 50 mg, 5 mg.
Vatalanib succinate is a succinate salt obtained by combining vatalanib with one molar equivalent of succinic acid. It is a multi-targeted tyrosine kinase inhibitor for all isoforms of VEGFR, PDGFR and c-Kit. It has a role as an antineoplastic agent, an angiogenesis inhibitor, an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor and a vascular endothelial growth factor receptor antagonist. It contains a vatalanib.
Source: ChEBI
| Molecular formula | C24H21ClN4O4 |
|---|---|
| Molecular weight | 464.9 g/mol |
| IUPAC name | butanedioic acid;N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine |
| InChIKey | LLDWLPRYLVPDTG-UHFFFAOYSA-N |
| SMILES | C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4.C(CC(=O)O)C(=O)O |
Computed by PubChem (NCBI)